AAMU
WST icon

APG Asset Management US’s West Pharmaceutical WST Stock Holding History

APG Asset Management US’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,499
Closed -$407K – 181
2025
Q3 		$407K Hold
1,499
– – ﹤0.01% 169
2025
Q2 		$333K Hold
1,499
– – ﹤0.01% 173
2025
Q1 		$330K Hold
1,499
– – ﹤0.01% 183
2024
Q4 		$491K Sell
1,499
-4,326
-74% -$1.36M ﹤0.01% 166
2024
Q3 		$1.75M Sell
5,825
-64,308
-92% -$19.7M 0.01% 100
2024
Q2 		$22.8M Buy
70,133
+1,813
+3% +$641K 0.13% 92
2024
Q1 		$27.1M Buy
68,320
+21,514
+46% +$7.96M 0.16% 78
2023
Q4 		$16.5M Buy
+46,806
New +$16.6M 0.1% 78

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

APG Asset Management US's WST Position: Q4 2025 in Review

APG Asset Management US sold out of West Pharmaceutical (WST) in Q4 2025, closing a stake of 1,499 shares — an estimated $407K sold.

APG Asset Management US first reported a position in WST in Q4 2023 and held it in 8 quarters. The position peaked at $27.1M in Q1 2024. 804 funds tracked by Wall St. Rank hold WST as of Q4 2025.

  • APG Asset Management US reported no remaining West Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • APG Asset Management US sold 1,499 West Pharmaceutical shares in Q4 2025, an estimated $407K.
  • APG Asset Management US first reported a position in West Pharmaceutical in Q4 2023 and held it in 8 quarters.
  • APG Asset Management US's West Pharmaceutical position peaked at $27.1M in Q1 2024.
  • 804 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.